Learn More
Medchemexpress LLC Amxi-5001 | 2170491-77-5 | MFCD34676674 | 98.3% | 457.46 | C25H20FN5O3 | 5 MG

Supplier: Medchemexpress LLC HY1457345MG
AMXI-5001 is a small-molecule research compound described as a potent, orally active dual PARP1/2 and microtubule polymerization inhibitor with selective antitumor cytotoxicity in multiple human cancer cell lines; it has demonstrated tumor regression in preclinical studies.
- Potent dual PARP1/2 and microtubule polymerization inhibition.
- Selective antitumor cytotoxicity across various human cancer cell lines.
- High purity suitable for research applications.
- Soluble in DMSO at 50 mg/mL with warming and sonication recommended.
- Stable as a powder when stored at -20°C for long-term storage.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.